Cargando…

mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in Portugal, February to August 2021

Through deterministic data linkage of health registries, mRNA vaccine effectiveness (VE) against COVID-19-related hospitalisations and deaths was measured in 1,880,351 older adults. VE against hospitalisations was 94% (95% confidence interval (CI): 88–97) and 82% (95% CI: 72–89) for those 65–79 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nunes, Baltazar, Rodrigues, Ana Paula, Kislaya, Irina, Cruz, Camila, Peralta-Santos, André, Lima, João, Pinto Leite, Pedro, Sequeira, Duarte, Matias Dias, Carlos, Machado, Ausenda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2021
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462036/ https://www.ncbi.nlm.nih.gov/pubmed/34558406 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.38.2100833

Ejemplares similares

COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged ≥65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021
por: Machado, Ausenda, et al.
Publicado: (2022)

COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: cohort study based on electronic health records, Portugal, May to July 2022
por: Kislaya, Irina, et al.
Publicado: (2022)

Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
por: Sentís, Alexis, et al.
Publicado: (2022)

Impact of stringent non-pharmaceutical interventions applied during the second and third COVID-19 epidemic waves in Portugal, 9 November 2020 to 10 February 2021: an ecological study
por: Torres, Ana Rita, et al.
Publicado: (2022)

Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021
por: Borges, Vítor, et al.
Publicado: (2021)

Measles outbreak after 12 years without endemic transmission, Portugal, February to May 2017
por: George, Francisco, et al.
Publicado: (2017)

Impact of national influenza vaccination strategy in severe influenza outcomes among the high-risk Portuguese population
por: Machado, Ausenda, et al.
Publicado: (2019)

Challenging measles case definition: three measles outbreaks in three Health Regions of Portugal, February to April 2018
por: Augusto, Gonçalo Figueiredo, et al.
Publicado: (2018)

Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially increasing hospitalisation rate, February 2021, Rio Grande do Sul, Southern Brazil
por: Martins, Andreza Francisco, et al.
Publicado: (2021)

Rapid spread of a novel NDM-producing clone of Klebsiella pneumoniae CC147, Northern Italy, February to August 2023
por: Mileto, Irene, et al.
Publicado: (2023)

Excess pneumonia and influenza hospitalizations associated with influenza epidemics in Portugal from season 1998/1999 to 2014/2015
por: Rodrigues, Emanuel, et al.
Publicado: (2018)

Outbreak of Salmonella enterica serotype Poona in infants linked to persistent Salmonella contamination in an infant formula manufacturing facility, France, August 2018 to February 2019
por: Jones, Gabrielle, et al.
Publicado: (2019)

Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022
por: Bastard, Jonathan, et al.
Publicado: (2022)

Combining self-reported and objectively measured survey data to improve hypertension prevalence estimates: Portuguese experience
por: Kislaya, Irina, et al.
Publicado: (2021)

Measuring the impact of COVID-19 vaccination and immunity waning: A modelling study for Portugal
por: Caetano, Constantino, et al.
Publicado: (2022)

Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021
por: Lee, Eunju, et al.
Publicado: (2021)

The silent epidemic of lymphogranuloma venereum inside the COVID-19 pandemic in Madrid, Spain, March 2020 to February 2021
por: Martínez-García, Laura, et al.
Publicado: (2021)

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
por: Seppälä, Elina, et al.
Publicado: (2021)

Misidentification of meticillin-resistant Staphylococcus aureus by the Cepheid Xpert MRSA NxG assay, the Netherlands, February to March 2021
por: Sabat, Artur J, et al.
Publicado: (2021)

Surge in SARS-CoV-2 transmission in school-aged children and household contacts, England, August to October 2021
por: Chudasama, Dimple Y, et al.
Publicado: (2021)

Risk and protective factors for SARS-CoV-2 reinfections, surveillance data, Italy, August 2021 to March 2022
por: Sacco, Chiara, et al.
Publicado: (2022)

Impact of influenza vaccination programmes among the elderly population on primary care, Portugal, Spain and the Netherlands: 2015/16 to 2017/18 influenza seasons
por: Machado, Ausenda, et al.
Publicado: (2019)

Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022
por: Coppi, Marco, et al.
Publicado: (2022)

Unexposed populations and potential COVID-19 hospitalisations and deaths in European countries as per data up to 21 November 2021
por: Chapman, Lloyd A C, et al.
Publicado: (2022)

Case series of four re-infections with a SARS-CoV-2 B.1.351 variant, Luxembourg, February 2021
por: Staub, Thérèse, et al.
Publicado: (2021)

Excess Mortality Associated with Influenza Epidemics in Portugal, 1980 to 2004
por: Nunes, Baltazar, et al.
Publicado: (2011)

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Initial assessment of the COVID-19 vaccination’s impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021
por: Nicolay, Nathalie, et al.
Publicado: (2021)

Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021
por: Kroidl, Inge, et al.
Publicado: (2021)

Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January−September 2021
por: Sacco, Chiara, et al.
Publicado: (2021)

Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021
por: de Gier, Brechje, et al.
Publicado: (2021)

Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021
por: Fernández-Prada, María, et al.
Publicado: (2021)

End of season 2022/2023 quadrivalent influenza vaccine effectiveness in preventing influenza in primary care in Portugal
por: Kislaya, Irina, et al.
Publicado: (2023)

COVID-19 trends and severity among symptomatic children aged 0–17 years in 10 European Union countries, 3 August 2020 to 3 October 2021
por: Bundle, Nick, et al.
Publicado: (2021)

Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal
por: Kislaya, Irina, et al.
Publicado: (2023)

Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022
por: Perez Duque, Mariana, et al.
Publicado: (2022)

mRNA vaccine effectiveness against hospitalisation due to severe acute respiratory infection (SARI) COVID-19 during Omicron variant predominance estimated from real-world surveillance data, Slovenia, February to March 2022
por: Grgič Vitek, Marta, et al.
Publicado: (2022)

Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021
por: Grgič Vitek, Marta, et al.
Publicado: (2022)

Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
por: de Gier, Brechje, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i284nvuao3mv9icv2egnf1q5p8